NCT04904133

Brief Summary

This study aims to determine the effects of chronic exposure to some low/no calorie sweeteners (LNCS) on glucose tolerance and glucagon like peptide 1 (GLP-1) release in healthy individuals. LNCS examined in this study are saccharin, sucralose and aspartame+acesulfame-K. The amounts of LNCS given to the participants are kept similar to daily life exposure; far less than the Acceptable Daily Intakes (ADIs) levels proposed by Food and Drug Administration (FDA) or European Food Safety Authority (EFSA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 2, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2019

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

May 14, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 27, 2021

Completed
Last Updated

May 27, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

May 14, 2021

Last Update Submit

May 22, 2021

Conditions

Keywords

artificial sweetenersnon-nutritive sweetenersoral glucose toleranceglucagon-like peptide-1insulin secretionsatiety peptides

Outcome Measures

Primary Outcomes (3)

  • 3 Hours Plasma Glucose

    Change from baseline plasma glucose levels at 4 weeks observed. Participants underwent a 3-h oral glucose tolerance test (3-h OGTT) by consuming a 250 mL 75 g glucose solution, and blood samples were collected at 60, 120, 180 min.

    3 hours

  • 3 Hours Plasma Insulin

    Change from baseline insulin levels at 4 weeks observed. Participants underwent a 3-h oral glucose tolerance test (3-h OGTT) by consuming a 250 mL 75 g glucose solution, and blood samples were collected at 60, 120, 180 min.

    3 hours

  • Glucagon-like peptide-1 (GLP-1) release

    Change from baseline fasting GLP-1 levels at 4 weeks observed.

    Week 4

Secondary Outcomes (6)

  • Body Weight

    Week 4

  • Fat Mass

    Week 4

  • Fat-Free Mass

    Week 4

  • Total Body Water

    Week 4

  • Body Mass Index (BMI)

    Week 4

  • +1 more secondary outcomes

Study Arms (4)

Saccharine Group

ACTIVE COMPARATOR

140 mg saccharin (Hermesetas) dissolved in 330 mL water for 4 weeks.

Other: Low/No Calorie Sweeteners

Sucralose Group

ACTIVE COMPARATOR

66 mg sucralose (Splenda) dissolved in 330 mL water for 4 weeks.

Other: Low/No Calorie Sweeteners

Aspartame+Acesulfame-K Group

ACTIVE COMPARATOR

88 mg aspartame+88 mg acesulfame-K (Takita) dissolved in 330 mL water for 4 weeks.

Other: Low/No Calorie Sweeteners

Control Group

PLACEBO COMPARATOR

330 mL water for 4 weeks.

Other: Placebo Group

Interventions

LNCS powdered and then dissolved in water.

Aspartame+Acesulfame-K GroupSaccharine GroupSucralose Group

Water

Also known as: Control
Control Group

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy,
  • Normoglycemic,
  • Female,
  • years old,
  • Weight-stable past 3 months

You may not qualify if:

  • Insulin resistance,
  • Type 2 diabetes mellitus,
  • Presence of acute/chronic infection,
  • Use of medication that may affect glucose metabolism (thiazide diuretics, glucocorticoids, estrogen or beta blockers)
  • Chronic alcohol intake,
  • Regular consumption of diet soda (more than one can of soda per week)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acıbadem Dr. Şinasi Can (Kadıköy) Hospital

Istanbul, Anadolu, 34718, Turkey (Türkiye)

Location

Related Publications (13)

  • Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.

    PMID: 25231862BACKGROUND
  • Rogers PJ, Hogenkamp PS, de Graaf C, Higgs S, Lluch A, Ness AR, Penfold C, Perry R, Putz P, Yeomans MR, Mela DJ. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond). 2016 Mar;40(3):381-94. doi: 10.1038/ijo.2015.177. Epub 2015 Sep 14.

    PMID: 26365102BACKGROUND
  • Miller PE, Perez V. Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies. Am J Clin Nutr. 2014 Sep;100(3):765-77. doi: 10.3945/ajcn.113.082826. Epub 2014 Jun 18.

    PMID: 24944060BACKGROUND
  • Toews I, Lohner S, Kullenberg de Gaudry D, Sommer H, Meerpohl JJ. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ. 2019 Jan 2;364:k4718. doi: 10.1136/bmj.k4718.

    PMID: 30602577BACKGROUND
  • Romo-Romo A, Aguilar-Salinas CA, Brito-Cordova GX, Gomez Diaz RA, Vilchis Valentin D, Almeda-Valdes P. Effects of the Non-Nutritive Sweeteners on Glucose Metabolism and Appetite Regulating Hormones: Systematic Review of Observational Prospective Studies and Clinical Trials. PLoS One. 2016 Aug 18;11(8):e0161264. doi: 10.1371/journal.pone.0161264. eCollection 2016.

    PMID: 27537496BACKGROUND
  • Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M, Bernier M, Mosinger B, Margolskee RF, Egan JM. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15069-74. doi: 10.1073/pnas.0706890104. Epub 2007 Aug 27.

    PMID: 17724330BACKGROUND
  • Brown RJ, Rother KI. Non-nutritive sweeteners and their role in the gastrointestinal tract. J Clin Endocrinol Metab. 2012 Aug;97(8):2597-605. doi: 10.1210/jc.2012-1475. Epub 2012 Jun 7.

    PMID: 22679063BACKGROUND
  • Nakagawa Y, Nagasawa M, Yamada S, Hara A, Mogami H, Nikolaev VO, Lohse MJ, Shigemura N, Ninomiya Y, Kojima I. Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One. 2009;4(4):e5106. doi: 10.1371/journal.pone.0005106. Epub 2009 Apr 8.

    PMID: 19352508BACKGROUND
  • Fujita Y, Wideman RD, Speck M, Asadi A, King DS, Webber TD, Haneda M, Kieffer TJ. Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo. Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E473-9. doi: 10.1152/ajpendo.90636.2008. Epub 2008 Dec 23.

    PMID: 19106249BACKGROUND
  • Sylvetsky AC, Brown RJ, Blau JE, Walter M, Rother KI. Hormonal responses to non-nutritive sweeteners in water and diet soda. Nutr Metab (Lond). 2016 Oct 21;13:71. doi: 10.1186/s12986-016-0129-3. eCollection 2016.

    PMID: 27777606BACKGROUND
  • Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G735-9. doi: 10.1152/ajpgi.90708.2008. Epub 2009 Feb 12.

    PMID: 19221011BACKGROUND
  • Temizkan S, Deyneli O, Yasar M, Arpa M, Gunes M, Yazici D, Sirikci O, Haklar G, Imeryuz N, Yavuz DG. Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes. Eur J Clin Nutr. 2015 Feb;69(2):162-6. doi: 10.1038/ejcn.2014.208. Epub 2014 Oct 1.

    PMID: 25271009BACKGROUND
  • Orku SE, Suyen G, Bas M. The effect of regular consumption of four low- or no-calorie sweeteners on glycemic response in healthy women: A randomized controlled trial. Nutrition. 2023 Feb;106:111885. doi: 10.1016/j.nut.2022.111885. Epub 2022 Nov 1.

Study Officials

  • Saziye E Orku, Dr.

    Acibadem University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants were not informed about the study group and also which sweetener they consumed.
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Volunteers were randomly divided into 4 groups (saccharin, sucralose, aspartame+acesulfame-K \[Asp+Ace-K\], control) and asked to drink the LNCS sweetened water once a day for 4-wks. All study groups and concentration of LNCS they consumed written as follows; Saccharin group: 330 mL water + 140 mg saccharine Sucralose group: 330 mL water + 66 mg sucralose Asp+Ace-K group: 330 mL water + 88 mg aspartame and 88 mg acesulfame-K Control group IV: 330 mL water only
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D, Department of Nutrition and Dietetics, Acıbadem University

Study Record Dates

First Submitted

May 14, 2021

First Posted

May 27, 2021

Study Start

April 2, 2019

Primary Completion

May 12, 2019

Study Completion

July 2, 2019

Last Updated

May 27, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations